Renibus Therapeutics® ("Renibus"), a clinical-stage biopharmaceutical company focusing on the prevention and treatment of ...
RINGANA, the Austrian skincare and life science company known for its freshly produced cosmetics and supplements, will officially enter the United States in November 2026, marking a major new chapter ...
What happened?Artificial intelligence (AI) has developed as a technology to support information processing, such as text generation, information organization, and programming.However, AI is now ...
Luma Group has closed its inaugural life sciences venture capital fund, LumaBio Fund I, with $410 million in committed ...
A ccording to the CBRE U.S. Life Sciences Outlook 2025 report, U.S life sciences employment hit a record high in 2024, and more job growth is expected in 2025. Meanwhile, the life sciences sector ...
Life sciences companies have long relied on evergreening strategies to strengthen patent exclusivity around innovative therapies.
TriSalus Life Sciences said it received Food and Drug Administration 510 (k) clearance for a new pressure-enabled drug delivery device. Shares surged 26% to $6.21 on the news after Tuesday's closing ...
BioTech Social Inc. (BSI) has established an advisory board of experts from various fields to enhance financial ...
Telangana IT Minister D. Sridhar Babu highlights the shift of Global Capability Centres from support roles to strategic innovation hubs, positioning Hyderabad as a key player in the global life ...
Buoyed by the rapid development of COVID-19 vaccines, the life sciences industry is on track for a succession of upheavals already transforming patient care, business models, and market dynamics. In ...
On September 23, 2026, JP Morgan downgraded its outlook for Wave Life Sciences (NASDAQGM:WVE) from Overweight to Neutral. This rating action occurred following a pre-action close of $4.35 on September ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results